[Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
作者信息
Bonnet F, Matamis D, Lepresle E, Cabane J, Le Gall J R
出版信息
Nouv Presse Med. 1982 May 1;11(20):1570-1.
PMID:7048249
Abstract
摘要
相似文献
1
[Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].[硬皮病中的恶性动脉高血压。卡托普利对肺血管和体循环血管阻力的有益作用]
Nouv Presse Med. 1982 May 1;11(20):1570-1.
2
[Beneficial effect of the converting enzyme inhibitor on the acute renal failure of scleroderma with arterial hypertension].[转换酶抑制剂对硬皮病合并动脉高血压急性肾衰竭的有益作用]
Nouv Presse Med. 1981 Apr 30;10(19):1596.
3
[Scleroderma complicated by arterial hypertension and kidney failure: treatment with captopril].[硬皮病合并动脉高血压和肾衰竭：卡托普利治疗]
Nouv Presse Med. 1981 May 16;10(22):1848.
4
Captopril in the treatment of scleroderma renal crisis.卡托普利治疗硬皮病肾危象
Arch Intern Med. 1984 Apr;144(4):733-5.
5
[Scleroderma complicated by arterial hypertension and renal insufficiency. Favorable effects of captopril].[硬皮病合并动脉高血压和肾功能不全。卡托普利的良好疗效]
Nouv Presse Med. 1980 Oct 4;9(36):2658.
6
Clinical course of patients with scleroderma renal crisis treated with captopril.
Nephron. 1981;27(2):74-8. doi: 10.1159/000182028.
7
8
Hypertensive crisis in systemic sclerosis: treatment with the new oral angiotensin converting enzyme inhibitor MK, 421 (Enalapril) in captopril-intolerant patients.
Arthritis Rheum. 1984 Jul;27(7):826-8. doi: 10.1002/art.1780270716.
9
[Usefulness of combined captopril-labetalol treatment in resistant hypertension (author's transl)].
Nouv Presse Med. 1982 May 8;11(21):1611-3.
10
[Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
Nouv Presse Med. 1981 Apr 30;10(19):1575-8.
Zotero 插件